SRXN1
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| sulfiredoxin 1 | MIM:617583 | Ensembl:ENSG00000271303 | HGNC:HGNC:16132 | PA25681 | 20p13 |
GO terms in SRXN1
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| BP | IDA | GO:0006979 | response to oxidative stress |
| BP | IBA | GO:0034599 | cellular response to oxidative stress |
| BP | IEA | GO:0055114 | oxidation-reduction process |
| BP | IEA | GO:0098869 | cellular oxidant detoxification |
| CC | IDA | GO:0005829 | cytosol |
| MF | IPI | GO:0005515 | protein binding |
| MF | IEA | GO:0005524 | ATP binding |
| MF | IDA | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors |
| MF | IBA | GO:0032542 | sulfiredoxin activity |
Gene expression in normal tissue: SRXN1
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in SRXN1
| Database | Pathway ID | Pathway Des. |
|---|---|---|
| wikipathways | WP3612 | Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in SRXN1
CLASSFICATION
Copyright © 2018 Modellab | All Rights Reserved
Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.